Arquivos do dia: Maio 23, 2022

Diretriz científica AHA | Prevenção e manejo de quedas em adultos com doença cardiovascular.

23 Mai, 2022 | 13:40h

Preventing and Managing Falls in Adults With Cardiovascular Disease: A Scientific Statement From the American Heart Association – Circulation: Cardiovascular Quality and Outcomes

Comunicado de imprensa: Statement addresses ways to prevent heart-related risks for falling – American Heart Association

Comentário: AHA News: Falls Can Be a Serious, Poorly Understood Threat to People With Heart Disease – HealthDay

---

OMS | Relatório de progresso 2022 sobre o plano de ação global para vidas saudáveis e bem-estar para todos.

23 Mai, 2022 | 13:39h

2022 Progress report on the Global Action Plan for Healthy Lives and Well-being for All – World Health Organization

Relatório completo: Stronger collaboration for an equitable and resilient recovery towards the health-related Sustainable Development Goals, incentivizing collaboration – World Health Organization

 

Comentário no Twitter (fio – clique para saber mais)

Progress on the health-related SDGs is further off track – countries have achieved only about one-fourth of what is needed to achieve the SDG health targets by 2030: Global Action Plan for Healthy Lives & Well-being for All #SDG3GAP progress report.

More https://t.co/HF8LO5UbVo pic.twitter.com/kGXoMTHnnh

— World Health Organization (WHO) (@WHO) May 18, 2022

 

---

OMS valida a 11ª vacina contra COVID-19.

23 Mai, 2022 | 13:37h

WHO validates 11th vaccine for COVID-19 – World Health Organization

 

Comentário no Twitter

WHO issued an emergency use listing for CONVIDECIA, a vaccine manufactured by CanSino Biologics, China, adding to a growing portfolio of #COVID19 vaccines validated by WHO https://t.co/QdpHiasT2p pic.twitter.com/2B54FwiNDl

— World Health Organization (WHO) (@WHO) May 19, 2022

 

---

Evidência sobre COVID-19: uma coletânea Cochrane.

23 Mai, 2022 | 13:36h

COVID-19 evidence: a Cochrane round-up – Cochrane Library

---

Revisão sistemática | Exames de imagem torácica para diagnóstico de COVID-19.

23 Mai, 2022 | 13:34h

Thoracic imaging tests for the diagnosis of COVID‐19 – Cochrane Library

Resumo: How accurate is chest imaging for diagnosing COVID-19? – Cochrane Library

Conteúdo relacionado: Review of Thoracic Imaging Manifestations of COVID-19 and Other Pathologic Coronaviruses – Radiology Clinics of North America

---

M-A | Duração do curso de antibióticos para pneumonia adquirida na comunidade em pacientes pediátricos ambulatoriais em países de alta renda – Tratamento com duração de 3-5 dias é tão efetivo e seguro quanto 7-10 dias.

23 Mai, 2022 | 13:33h

Antibiotic treatment duration for community acquired pneumonia in outpatient children in high-income countries – a systematic review and meta-analysis – Clinical Infectious Diseases

Conteúdos relacionados:

Antibiotics for Pediatric Pneumonia: Might Less Be Enough? – Annals of Emergency Medicine

Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia: The CAP-IT Randomized Clinical Trial – JAMA

Extended Versus Standard Antibiotic Course Duration in Children <5 Years of Age Hospitalized With Community-acquired Pneumonia in High-risk Settings: Four-week Outcomes of a Multicenter, Double-blind, Parallel, Superiority Randomized Controlled Trial – The Pediatric Infectious Disease Journal

Short- vs Standard-Course Outpatient Antibiotic Therapy for Community-Acquired Pneumonia in Children: The SCOUT-CAP Randomized Clinical Trial – JAMA Pediatrics

Appropriate Use of Short-Course Antibiotics in Common Infections: Best Practice Advice From the American College of Physicians – Annals of Internal Medicine

Short-Course Antimicrobial Therapy for Pediatric Community-Acquired Pneumonia: The SAFER Randomized Clinical Trial – JAMA Pediatrics

Efficacy of short-course antibiotic treatments for community-acquired pneumonia in adults: A systematic review and meta-analysis – Antimicrobial Agents and Chemotherapy

 

Comentário no Twitter

Antibiotic treatment duration for community acquired pneumonia in outpatient children in high-income countries – a systematic review and meta-analysis https://t.co/HxKywgCiXS
A short AB treatment of 3–5 days was equally effective and safe compared to the longer – 7–10 days

— Alexander V. Veselov 😷 (@veselov78) May 17, 2022

 

---

Covid-19 | OMS afirma que o segundo reforço de vacina pode ser benéfico em grupos de alto risco, mas tem um impacto “mínimo” para outros grupos.

23 Mai, 2022 | 13:31h

Covid-19: Second boosters may benefit at-risk groups but have “minimal” impact for others, says WHO – The BMJ

Diretriz original: Interim statement on the use of additional booster doses of Emergency Use Listed mRNA vaccines against COVID-19 – World Health Organization

Recomendações relacionadas:

COVID-19: Joint statement from ECDC and EMA on the administration of a fourth dose of mRNA vaccines –
European Centre for Disease Prevention and Control

Coronavirus (COVID-19) Update: FDA Authorizes Second Booster Dose of Two COVID-19 Vaccines for Older and Immunocompromised Individuals – U.S. Food & Drug Administration

---

Reativação sanguínea do citomegalovírus em pacientes críticos com COVID-19: fatores de risco e impacto sobre a mortalidade.

23 Mai, 2022 | 13:29h

Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality – Intensive Care Medicine

 

Comentário no Twitter

CMV reactivation in #COVID19 critically ill pts:
🦠frequent! >20% in this study
🧪risk depends on severity of illness/occurrence of secondary bacterial infections in #ICU
🏥 prolonged hospital stay & higher mortality but independent association lacking.
📎 https://t.co/N8JVD1GyPQ pic.twitter.com/KYRtLmxtJg

— Intensive Care Medicine (@yourICM) May 18, 2022

 

---

Diretrizes SCAI para tratamento do forame oval patente.

23 Mai, 2022 | 13:28h

SCAI Guidelines for the Management of Patent Foramen Ovale – JSCAI

Editorial: New SCAI Guidelines: Trying to Close the Holes in the PFO Literature – JSCAI

Comentário: PFO Closure Guidelines Address Older Adults, Trial-Excluded Groups— Document acknowledges skimpy evidence – MedPage Today (free registration required)

Conteúdos relacionados:

Advances in the management of cardioembolic stroke associated with patent foramen ovale – The BMJ

Practice advisory update summary: Patent foramen ovale and secondary stroke prevention: Report of the Guideline Subcommittee of the American Academy of Neurology – Neurology

Heterogeneity of Treatment Effects in an Analysis of Pooled Individual Patient Data From Randomized Trials of Device Closure of Patent Foramen Ovale After Stroke – JAMA (link para o resumo – $ para o texto completo)

Management of the Patient With Patent Foramen Ovale in 2021: A Spectrum of Cases – Mayo Clinic Proceedings

---

Estudo randomizado | Apixaban não é superior ao cuidado padrão (antagonista de vitamina K e terapia antiplaquetária se a anticoagulação for ou não indicada, respectivamente) após implante de válvula aórtica transcateter.

23 Mai, 2022 | 13:27h

Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial – European Heart Journal (link para o resumo – $ para o texto completo)

Editorial: Defining optimal antithrombotic therapy post-TAVI: the contribution of ATLANTIS – European Heart Journal

Conteúdos relacionados:

Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical Trial – Circulation

Comparing Single- and Dual-Antiplatelet Therapies After Transcatheter Aortic Valve Implantation – The Annals of Thoracic Surgery

Aspirin Alone Versus Dual Antiplatelet Therapy After Transcatheter Aortic Valve Implantation: A Systematic Review and Patient‐Level Meta‐Analysis – Journal of the American Heart Association

Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation – New England Journal of Medicine

Anti-Thrombotic Strategy to Lower All cardiovascular and Neurologic Ischemic and Hemorrhagic Events after Trans-Aortic Valve Implantation for Aortic Stenosis – ATLANTIS – American College of Cardiology

---